Trials by Active Ingredient
Tapentadol
| Trial identifier (Sponsor): | KF5503/44 |
| Trade name: | Palexia®, Nucynta®, Yantil® |
| INN / Sponsor substance code: | Tapentadol |
| Trial title: | An evaluation of the effectiveness and tolerability of tapentadol hydrochloride prolonged release, and tapentadol hydrochloride immediate release on demand, in subjects with uncontrolled severe chronic nociceptive, mixed or neuropathic low back pain taking either WHO Step I or Step II analgesics or no regular analgesics |
| Brief title: | -- |
| Trial indication: | Chronic nociceptive, mixed or neuropathic low back pain |
| Trial status: | Completed |
| Results posted: | Yes (Clinical Trials.gov, Eudra CT) |
| PubMed unique identifier [PMID]: | 22443293 |
| First subject enrolled: | 30 Sep 2009 |
| Last subject completed: | 06 Jul 2010 |
| UTN (WHO): | -- |
| ClinicalTrials.gov identifier: | NCT00983385 |
| Eudra CT identifier: | 2009-010427-12 |
| Available for data sharing: | No |
| Trial phase: | 3b |
